Network quantification of EGFR signaling unveils potential for targeted combination therapy. [electronic resource]
Producer: 20130913Description: 673 p. digitalISSN:- 1744-4292
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Drug Screening Assays, Antitumor
- Drug Therapy, Combination
- ErbB Receptors -- genetics
- Extracellular Signal-Regulated MAP Kinases -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- Mice, Nude
- Models, Genetic
- Phosphatidylinositol 3-Kinases -- genetics
- Protein Interaction Maps -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins c-akt -- genetics
- Signal Transduction -- drug effects
- Transplantation, Heterologous
- Tumor Burden -- drug effects
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.